Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition
Resource MedicinalProductDefinition "5772a6f2-cde1-4903-bfcf-1639340205cc"
Profile: Drug Product Description
description: A tablet consisting of two layers where one provides immediate release and of the two drugs (Figure in 3.2.P.1.3). Both immediate-release layers are composed of granules with a matrix layer for the modified release of the drug.
combinedPharmaceuticalDoseForm: TABLET, MULTILAYER (Dummy NCIT Codesystem#C42964)
route: ORAL (Dummy NCIT Codesystem#C38288)
name
productName: ASPIRIN 200mg, ACETAMINOPHEN 300mg
type: Non-Proprietary (Product Name Types Code Types#NON)
part
part: ASPIRIN
type: scientific name (EntityNamePartQualifierR2#SCI)
part
part: 200mg
type: strength name (EntityNamePartQualifierR2#STR)
part
part: ACETAMINOPHEN
type: scientific name (EntityNamePartQualifierR2#SCI)
part
part: 300mg
type: strength name (EntityNamePartQualifierR2#STR)